BERKELEY, CA - Caribou Biosciences, Inc., a company specializing in biological products, announced the upcoming resignation of its Chief Financial Officer (CFO), Jason O’Byrne, effective September 27, 2024. O’Byrne is stepping down to pursue a new opportunity. His departure is not due to any disagreements with the company on matters of financial reporting or accounting practices.
Following O’Byrne's resignation, Ryan Fischesser, currently serving as the Vice President of Finance and Controller, will take over as the principal accounting officer. Fischesser, 38, has been with Caribou Biosciences since February 2017 and has a history of leadership within the company's finance department. Before joining Caribou, he co-founded the CPA firm BHLF LLP. Fischesser holds a B.S. in Business Administration from Saint Mary’s College of California.
The company has begun searching for a new CFO to fill the upcoming vacancy. Fischesser's appointment to the role of principal accounting officer will take effect at the close of business on September 27, the same day O’Byrne will officially step down.
Caribou Biosciences, incorporated in Delaware and headquartered in Berkeley, California, is listed on the NASDAQ Global Select Market under the ticker CRBU. The internal transition comes at a time when the company is not reporting any related transactions that would require additional disclosure under SEC regulations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.